As of 3:40pm ET
| -0.0432 / -5.58%|
The 2 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 9.25, with a high estimate of 10.50 and a low estimate of 8.00. The median estimate represents a +1,166.43% increase from the last price of 0.73.
The current consensus among 2 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.